Medical Sciences Laboratory INC.
Medical Sciences Laboratory INC. was paid $1.59M by Medicaid between Jan 2018 and Aug 2022, across 47 billing codes. Its largest line is U0004, 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc, making use of high throughput technologies as described by cms-2020-01-r — 63% of everything it billed.
ANAHEIM, CA 92801
Next to other Clinical Medical Laboratory providers in California
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Paid by month
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 16,434 | $204K | |
| 2019 | 7,956 | $100K | |
| 2020 | 5,527 | $191K | |
| 2021 | 20,325 | $662K | |
| 2022 | 13,886 | $437K |
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| U0004 | 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc, making use of high throughput technologies as described by cms-2020-01-r | 63% | 15,410 | 11,541 | $1.00M |
| U0005 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 | 6.5% | 8,243 | 6,011 | $104K |
| 36415 | Collection of venous blood by venipuncture | 4.4% | 3,141 | 2,648 | $70K |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | 4.1% | 2,201 | 2,134 | $66K |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | 4.0% | 2,111 | 2,044 | $63K |
| 80061 | Lipid panel | 2.9% | 4,591 | 4,494 | $47K |
| 80053 | Comprehensive metabolic panel | 2.9% | 5,470 | 5,286 | $46K |
| 84443 | Thyroid stimulating hormone (TSH) | 2.8% | 3,414 | 3,339 | $44K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | 2.5% | 6,524 | 5,955 | $40K |
| 83036 | Hemoglobin; glycosylated (A1C) | 1.6% | 3,423 | 3,377 | $26K |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | 1.6% | 1,210 | 1,199 | $25K |
| 87389 | Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies | <1% | 819 | 805 | $16K |
35 more codes
| 86592 | <1% | 1,491 | $5K | |
| 81001 | <1% | 1,786 | $5K | |
| 84439 | <1% | 624 | $5K | |
| 82274 | <1% | 288 | $4K | |
| P9604 | Travel allowance one way in connection with medically necessary laboratory specimen collection drawn from home bound or nursing home bound patient; prorated trip charge | <1% | 548 | $4K |
| 86480 | <1% | 57 | $3K | |
| 84153 | <1% | 181 | $3K | |
| 82043 | <1% | 537 | $2K | |
| 82570 | <1% | 558 | $2K | |
| 84480 | <1% | 164 | $2K | |
| 87086 | Culture, bacterial; quantitative colony count, urine | <1% | 262 | $2K |
| 86769 | <1% | 75 | $1K | |
| 80164 | <1% | 126 | $1K | |
| 87624 | Infectious agent detection by nucleic acid; human papillomavirus (HPV), high-risk types | <1% | 39 | $1K |
| 84436 | <1% | 200 | $1K | |
| 87081 | <1% | 128 | $697.97 | |
| 80055 | <1% | 17 | $548.25 | |
| 86762 | <1% | 25 | $321.43 | |
| 99000 | <1% | 92 | $315.57 | |
| 82950 | <1% | 69 | $260.13 | |
| 84479 | <1% | 51 | $254.79 | |
| 86706 | <1% | 33 | $237.91 | |
| 84550 | <1% | 30 | $166.43 | |
| 87340 | <1% | 15 | $166.27 | |
| 86376 | <1% | 14 | $162.96 | |
| 82248 | <1% | 39 | $157.17 | |
| 86735 | <1% | 13 | $150.67 | |
| 86765 | <1% | 13 | $148.85 | |
| 86787 | <1% | 13 | $147.94 | |
| 82607 | <1% | 19 | $142.44 | |
| 83550 | <1% | 12 | $74.40 | |
| 86704 | <1% | 14 | $65.25 | |
| 83540 | <1% | 12 | $61.80 | |
| 86430 | <1% | 13 | $59.02 | |
| 82550 | <1% | 13 | $53.10 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.